Acutaas Chemicals Stock Screener | Share Price & Fundamental Analysis
ACUTAAS
Pharmaceuticals
Screen Acutaas Chemicals share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹1763.20
▲
5.10 (0.29%)
Share Price BSE
₹1762.10
▲
5.00 (0.28%)
Market Cap
₹14,321.72 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
10.13
EPS (TTM)
₹19.91
Dividend Yield
0.09%
Debt to Equity
0.12
52W High
₹1872.20
52W Low
₹940.90
Operating Margin
28.00%
Profit Margin
20.06%
Revenue (TTM)
₹314.00
EBITDA
₹91.00
Net Income
₹63.00
Total Assets
₹1,549.00
Total Equity
₹1,320.00
Acutaas Chemicals Share Price History - Stock Screener Chart
Screen ACUTAAS historical share price movements with interactive charts. Analyze price trends and patterns.
Acutaas Chemicals Company Profile - Fundamental Screener
Screen Acutaas Chemicals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ACUTAAS shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE00FF01025
Acutaas Chemicals Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen ACUTAAS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 1,549 | 1,096 | 767 | 659 | 413 | 232 | 213 |
| Current Assets | 792 | 496 | 457 | 430 | 216 | 121 | 124 |
| Fixed Assets | 570 | 427 | 259 | 205 | 186 | 85 | 79 |
| Liabilities | |||||||
| Total Liabilities | 1,549 | 1,096 | 767 | 659 | 413 | 232 | 213 |
| Current Liabilities | 27 | 128 | 10 | 7 | 80 | 26 | 25 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 1,320 | 683 | 594 | 522 | 167 | 112 | 82 |
| Share Capital | 41 | 37 | 36 | 36 | 32 | 11 | 11 |
| Reserves & Surplus | 1,269 | 637 | 558 | 486 | 135 | 101 | 72 |
Screen ACUTAAS income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 314 | 223 | 316 | 226 | 178 | 255 | 277 | 186 | 155 | 174 | 170 | 144 | 132 | 148 | 155 |
| Expenses | 224 | 156 | 211 | 182 | 147 | 198 | 206 | 146 | 120 | 179 | 140 | 118 | 108 | 119 | 122 |
| EBITDA | 91 | 67 | 105 | 44 | 31 | 57 | 70 | 41 | 35 | -5 | 30 | 26 | 24 | 29 | 34 |
| Operating Profit % | 28.00% | 25.00% | 31.00% | 19.00% | 17.00% | 20.00% | 25.00% | 22.00% | 22.00% | -4.00% | 16.00% | 18.00% | 18.00% | 19.00% | 20.00% |
| Depreciation | 7 | 8 | 8 | 5 | 6 | 7 | 6 | 3 | 4 | 4 | 4 | 3 | 3 | 3 | 3 |
| Interest | 1 | 1 | 1 | 2 | 4 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 0 | 0 | 1 |
| Profit Before Tax | 83 | 58 | 96 | 37 | 20 | 50 | 63 | 37 | 31 | -10 | 24 | 22 | 20 | 26 | 30 |
| Tax | 20 | 14 | 24 | 12 | 5 | 13 | 18 | 10 | 9 | 7 | 6 | 1 | 6 | 7 | 7 |
| Net Profit | 63 | 44 | 72 | 26 | 15 | 38 | 46 | 27 | 22 | -17 | 18 | 21 | 15 | 19 | 22 |
| EPS | 7.80 | 5.41 | 8.82 | 6.85 | 3.67 | 9.38 | 11.35 | 7.47 | 4.57 | -4.67 | 4.83 | 6.22 | 4.08 | 5.50 | 6.28 |
Acutaas Chemicals Cash Flow Screener - Liquidity Fundamentals
Screen ACUTAAS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 118 | 125 | 66 | -12 | 28 | 27 | 15 | 9 | 29 | 10 |
| Investing Activities | -224 | -365 | -33 | -121 | -101 | -24 | -21 | -25 | -19 | -14 |
| Financing Activities | 261 | 239 | -12 | 140 | 72 | 0 | 6 | 15 | -7 | 4 |
| Net Cash Flow | 156 | -1 | 20 | 8 | -1 | 3 | 0 | -2 | 3 | 0 |
Screen ACUTAAS shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-May | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 35.96% | 32.66% | 32.66% | 39.91% | 39.07% | 35.98% | 35.97% | 35.96% |
| FII Holding | 16.48% | 16.94% | 16.85% | 8.97% | 10.01% | 12.92% | 13.87% | 15.52% |
| DII Holding | 18.31% | 22.38% | 22.59% | 6.81% | 8.81% | 14.81% | 19.93% | 20.24% |
| Govt Holding | 0.01% | 0.01% | 0.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.01% |
| Public Holding | 24.19% | 23.27% | 22.79% | 30.01% | 28.79% | 26.06% | 24.72% | 23.56% |
| Other Holding | 5.05% | 4.74% | 5.10% | 14.30% | 13.33% | 10.22% | 5.51% | 4.71% |
| Shareholder Count | 114,060 | 119,890 | 108,664 | 95,784 | 92,721 | 90,329 | 93,394 | 95,756 |
Acutaas Chemicals Dividend Screener - Share Yield Analysis
Screen ACUTAAS dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹1.50 | 0.09% |
| 2024-March | ₹3.00 | 0.25% |
| 2023-March | ₹3.00 | 0.55% |
| 2022-March | ₹3.00 | 0.67% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Acutaas Chemicals Index Membership - Market Screener Classification
Screen ACUTAAS by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Acutaas Chemicals Market Events Screener - Corporate Actions
Screen ACUTAAS market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 10.98% | ||
| Dividend | ₹ 3.00 /share | 22.46% | ||
| Dividend | ₹ 3.00 /share | 22.48% | ||
| Annual General Meeting | NA | 2.58% | ||
| Dividend | ₹ 1.50 /share | 30.24% | ||
| 2025-10-17 | 2025-10-17 | Quarterly Result Announcement | NA | 9.19% |
| 2025-07-30 | 2025-07-30 | Quarterly Result Announcement | NA | -1.68% |
| 2025-05-10 | 2025-05-10 | Extraordinary General Meeting | NA | -1.46% |
| 2025-05-02 | 2025-05-02 | Quarterly Result Announcement | NA | 2.70% |
| 2025-04-25 | 2025-02-22 | Split | 5:10 | 0.00% |
| 2025-04-16 | 2025-04-16 | Change Of Name | NA | 0.00% |
| 2025-01-28 | 2025-01-28 | Quarterly Result Announcement | NA | -3.56% |
| 2024-10-29 | 2024-10-29 | Quarterly Result Announcement | NA | 9.42% |
| 2022-07-29 | 2022-08-01 | Dividend | ₹ 3.00 /share | 10.65% |
Acutaas Chemicals Competitors Screener - Peer Comparison
Screen ACUTAAS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 414,605 | 39.37 | 54,729 | 9.71% | 10,980 | 42.10 |
| Divis Laboratories | 169,701 | 67.76 | 9,712 | 18.67% | 2,191 | 48.20 |
| Torrent Pharmaceuticals | 131,496 | 60.85 | 11,539 | 6.99% | 1,911 | 67.66 |
| Cipla | 122,103 | 22.30 | 28,410 | 7.12% | 5,291 | 51.10 |
| Dr Reddys Laboratories | 104,838 | 18.24 | 33,741 | 16.73% | 5,725 | 45.31 |
| Lupin | 96,170 | 22.10 | 22,910 | 13.74% | 3,306 | 56.06 |
| Zydus Life Science | 92,262 | 18.30 | 23,511 | 18.55% | 4,615 | 45.37 |
| Mankind Pharma | 90,929 | 50.34 | 12,744 | 20.90% | 2,007 | 50.55 |
| Aurobindo Pharma | 70,591 | 20.25 | 32,346 | 9.43% | 3,484 | 56.45 |
| Alkem Laboratories | 66,867 | 27.11 | 13,458 | 3.70% | 2,216 | 50.91 |
Acutaas Chemicals Company Announcements - News Screener
Screen ACUTAAS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-01 | Closure of Trading Window | View |
| 2025-12-22 | Intimation Of Grant Of Stock Options Under Ami Organics ESOS 2023 | View |
| 2025-12-04 | Announcement under Regulation 30 (LODR)-Credit Rating | View |
| 2025-11-11 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-10-24 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-10-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-10-17 | Recording Of Earnings Conference Call Held On October 17 2025 | View |
| 2025-10-17 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-10-17 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-10-17 | Unaudited Standalone And Consolidated Financial Results For Second Quarter And Half Year Ended September 30 2025 | View |
| 2025-10-17 | Board Meeting Outcome for Outcome Of Board Meeting Held On October 17 2025 | View |
| 2025-10-10 | Intimation Of Earnings Conference Call Scheduled On Friday October 17 2025 At 3.30 P.M. (IST) | View |
| 2025-10-10 | Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025 To Be Held On October 17 2025 | View |
| 2025-10-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-26 | Closure of Trading Window | View |
| 2025-09-25 | Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 | View |
| 2025-09-25 | Announcement under Regulation 30 (LODR)-Allotment | View |
| 2025-09-25 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-25 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-03 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |